Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/34740
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNightscales, Russell-
dc.contributor.authorChen, Zhibin-
dc.contributor.authorBarnard, Sarah-
dc.contributor.authorAuvrez, Clarissa-
dc.contributor.authorTao, Gerard-
dc.contributor.authorSivathamboo, Shobi-
dc.contributor.authorBennett, Caitlin-
dc.contributor.authorRychkova, Maria-
dc.contributor.authorD'Souza, Wendyl-
dc.contributor.authorBerkovic, Samuel F-
dc.contributor.authorNicolo, John-Paul-
dc.contributor.authorO'Brien, Terence J-
dc.contributor.authorPerucca, Piero-
dc.contributor.authorScheffer, Ingrid E-
dc.contributor.authorKwan, Patrick-
dc.date2023-
dc.date.accessioned2024-01-03T22:57:56Z-
dc.date.available2024-01-03T22:57:56Z-
dc.date.issued2023-12-22-
dc.identifier.citationEpilepsia Open 2023-12-22en_US
dc.identifier.issn2470-9239-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/34740-
dc.description.abstractLennox-Gastaut syndrome (LGS) is an archetypal developmental and epileptic encephalopathy, for which novel treatments are emerging. Diagnostic criteria for LGS have recently been defined by the International League Against Epilepsy (ILAE). We aimed to apply these criteria in the real-world setting. We applied ILAE diagnostic criteria to a cohort of patients diagnosed with LGS by epileptologists following inpatient video-EEG monitoring (VEM) at tertiary comprehensive epilepsy centres between 1995 and 2015. We also assessed mortality in this cohort. Sixty patients diagnosed with LGS and had complete records available for review were Identified. Among them, 29 (48%) patients met ILAE diagnostic criteria for LGS (ILAE-DC group). Thirty-one did not meet criteria (non-ILAE-DC) due to absence of documented tonic seizures (n=7), EEG features (n=12), or both tonic seizures and EEG features (n=10), intellectual disability (n=1), or drug resistance (n=1). The ILAE-DC group had a shorter duration of epilepsy at VEM than the non-ILAE-DC group (median = 12.0 years Vs 23.7 years, respectively; p=0.015). The proportions of patients with multiple seizure types (100% vs. 96.7%), ≤2.5Hz slow spike-and-wave EEG activity (100% vs. 90%), seizure-related injuries (27.6% vs 25.8%), and mortality (standardized mortality ratio 4.60 vs. 5.12) were similar between the groups. Up to 52% of patients diagnosed with LGS following VEM may not meet recently accepted ILAE criteria for LGS diagnosis. This may reflect both the limitations of retrospective medical record review and a historical tendency of applying the LGS diagnosis to a broad spectrum of severe, early-onset drug-resistant epilepsies with drop attacks. The ILAE criteria allow delineation of LGS based on distinct electroclinical features, potentiating accurate diagnosis, prognostication, and management formulation. Nonetheless, mortality outcomes between those who did and did not meet ILAE diagnostic criteria for LGS were similarly poor, and both groups suffered high rates of seizure-related injury.en_US
dc.language.isoeng-
dc.titleApplying the ILAE diagnostic criteria for Lennox-Gastaut syndrome in the real-world setting: A multicentre retrospective cohort study.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleEpilepsia Openen_US
dc.identifier.affiliationDepartment of Neuroscience, Central Clinical School, Monash University, Melbourne, Victoria, Australia.;Department of Neurology, Alfred Health, Melbourne, Victoria, Australia.en_US
dc.identifier.affiliationNorthWestern Mental Health, Melbourne Health, Melbourne, Victoria, Australia.en_US
dc.identifier.affiliationDepartment of Medicine (The Royal Melbourne Hospital), The University of Melbourne, Victoria, Australia.en_US
dc.identifier.affiliationDepartment of Neuroscience, Central Clinical School, Monash University, Melbourne, Victoria, Australia.;Department of Neurology, Alfred Health, Melbourne, Victoria, Australia.;Department of Medicine (The Royal Melbourne Hospital), The University of Melbourne, Victoria, Australia.;Department of Neurology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.en_US
dc.identifier.affiliationEpilepsy Research Centre, Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, Victoria, Australia.en_US
dc.identifier.affiliationDepartment of Medicine (The Royal Melbourne Hospital), The University of Melbourne, Victoria, Australia.en_US
dc.identifier.affiliationDepartment of Medicine, St. Vincent's Hospital, The University of Melbourne, Fitzroy, Victoria, Australia.en_US
dc.identifier.affiliationEpilepsy Research Centreen_US
dc.identifier.affiliationNeurologyen_US
dc.identifier.doi10.1002/epi4.12894en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0001-9108-207Xen_US
dc.identifier.orcid0000-0002-1888-6917en_US
dc.identifier.orcid0000-0003-0517-2533en_US
dc.identifier.orcid0000-0003-4638-9579en_US
dc.identifier.orcid0000-0003-4580-841Xen_US
dc.identifier.orcid0000-0002-0473-6475en_US
dc.identifier.orcid0000-0002-7855-7066en_US
dc.identifier.orcid0000-0002-2311-2174en_US
dc.identifier.orcid0000-0001-7310-276Xen_US
dc.identifier.pubmedid38135919-
item.languageiso639-1en-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptMedicine (University of Melbourne)-
crisitem.author.deptEpilepsy Research Centre-
crisitem.author.deptNeurology-
crisitem.author.deptNeurology-
crisitem.author.deptComprehensive Epilepsy Program-
crisitem.author.deptEpilepsy Research Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

20
checked on May 22, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.